Pramod Kumar Rompikuntal

Pramod Kumar Rompikuntal is a Principal Scientist at GentiBio since April 2022, following a notable career in gene therapy and molecular biology. Previously, Pramod held the position of Senior Scientist at Takeda, where responsibilities included leading vector production and serving as a Scientist for Gene Therapy at Shire. Prior experience includes a role as a Molecular Biology Scientist at Xyleco and a Postdoctoral Research Associate at the University of Vermont, focusing on the motility of T. gondii. Educational qualifications include a PhD in Medical Molecular Biology, a Master’s in Molecular Biology, and another in Biotechnology, all obtained from Umeå University and Barkatullah University.